Study: Blood Thinner Safe for Cancer Patients with Brain Metastases
May 18, 2015
Cancer patients with brain metastases who develop blood clots may safely receive blood thinners without increased risk of dangerous bleeding, according to a study published online today in Blood, the Journal of the American Society of Hematology (ASH).
ASH Agenda for Hematology Research Identifies Top Priorities for Scientific Discovery
Apr 29, 2015
The American Society of Hematology, the world’s largest professional society committed to the study and treatment of blood disorders, today issued a report urging scientists and funding institutions to coordinate their efforts around six research areas with the strongest potential to make a dramatic impact on the care of patients with a wide range of diseases.
Fellows and Junior Faculty Participate in 2015 ASH Clinical Research Training Institute in Latin America
Apr 21, 2015
The American Society of Hematology today announced the names of ten hematologists selected to participate in the third ASH Clinical Research Training Institute in Latin America (CRTI-LA). This education and mentorship program, being held April 21-22, 2015, in Cartagena, Colombia, prior to the Society’s Highlights of ASH® meeting in Latin America, is designed to prepare current hematology and hematology/oncology fellows and junior faculty working in Latin America for careers in patient-oriented clinical research.